Where does Artax Biopharma's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Artax Biopharma's 8 recorded funding rounds.

Premier Alternatives

Artax Biopharma

Cambridge, MA · Founded 2013 · Privately Held (backing)

Developer of small-molecule drugs intended to treat autoimmune and inflammatory diseases. Artax Biopharma is based in Cambridge, MA and was founded in 2013. Its last reported valuation was $58 million in May 2022. It has raised $51.5 million across 8 recorded rounds; the latest was a $19 million early-stage round in Jul 2024.

Last reported valuation

$58.0M

Oct 2026

Priced at

—

Total raised

$51.5M

Last round

Early Stage VC

Jul 2024

Cap table — not yet on record

Artax Biopharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Artax Biopharma with a free account

·Watch Artax Biopharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Artax Biopharma

Where does Artax Biopharma's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Artax Biopharma's 8 recorded funding rounds.